Medipal Holdings P Stock Short Ratio
| 59Z Stock | EUR 13.90 0.20 1.42% |
MEDIPAL HOLDINGS P fundamentals help investors to digest information that contributes to MEDIPAL HOLDINGS's financial success or failures. It also enables traders to predict the movement of MEDIPAL Stock. The fundamental analysis module provides a way to measure MEDIPAL HOLDINGS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIPAL HOLDINGS stock.
MEDIPAL |
MEDIPAL HOLDINGS P Company Short Ratio Analysis
MEDIPAL HOLDINGS's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, MEDIPAL HOLDINGS P has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Distribution industry. The short ratio for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
MEDIPAL Fundamentals
| Return On Equity | 0.0597 | |||
| Return On Asset | 0.0161 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Shares Outstanding | 209.96 M | |||
| Shares Owned By Insiders | 9.02 % | |||
| Shares Owned By Institutions | 28.77 % | |||
| Price To Earning | 17.52 X | |||
| Revenue | 3.35 T | |||
| Gross Profit | 217.44 B | |||
| EBITDA | 60.12 B | |||
| Net Income | 26.47 B | |||
| Cash And Equivalents | 230.57 B | |||
| Total Debt | 30.36 B | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 1.23 X | |||
| Book Value Per Share | 2,636 X | |||
| Cash Flow From Operations | 34.45 B | |||
| Earnings Per Share | 0.89 X | |||
| Number Of Employees | 12.8 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 2.57 B | |||
| Annual Yield | 0.03 % | |||
| Last Dividend Paid | 23.0 |
About MEDIPAL HOLDINGS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIPAL HOLDINGS P's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIPAL HOLDINGS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIPAL HOLDINGS P based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in MEDIPAL Stock
MEDIPAL HOLDINGS financial ratios help investors to determine whether MEDIPAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDIPAL with respect to the benefits of owning MEDIPAL HOLDINGS security.